Same-day shipping now live from Irvine, CA · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Just dropped · The GLP Collection →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from Irvine, CA · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Just dropped · The GLP Collection →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
Home Β· ATX-304, O-304 and OS-01: Understanding the Names
ATX-304, O-304 and OS-01: Understanding the Names

Understand ATX-304, O-304 and the OS-01 naming ambiguity, including the unrelated skin peptide and why chemical form matters.

ATX-304 Β· O-304 research

ATX-304, O-304 and OS-01: Understanding the Names

Quick answer

ATX-304 was previously published as O304, often written O-304. OS-01 needs an identity check: some sellers use it for O304, while skin research uses OS-01 for a different peptide.

Disguised Alpha Β· November 10, 2026 Β· Research education

For laboratory research education. DA materials are not for human or veterinary use.

Which names belong together?

The 2025 ATX-304 paper explicitly identifies O304 as the compound’s former name. O-304 is the hyphenated spelling encountered in product searches. Searching both ATX-304 and O304 helps connect newer publications with earlier work.[1]

NameContextWhat to check
ATX-304 / ATX304Current development name and spelling variantExact chemical form and study material
O304 / O-304Earlier compound designationOriginal publication and formulation
OS-01Ambiguous across product categoriesSmall molecule or skin-research peptide?

Why OS-01 needs extra care

Published skin research identifies OS-01, also called Pep 14, as a senotherapeutic peptide. A 2024 split-face trial examined an OS-01-containing topical formulation against its vehicle in 22 participants. That evidence concerns the skin formulation and does not establish properties of ATX-304.[2]

Separately, a supplier listing uses OS-01 for capsules it describes as containing O304. This is evidence of that seller’s naming practice, not proof of a universal scientific synonym or of the capsule contents.[3]

Build a usable identity record

Start with the compound identity, then record its form, formulation, strength and lot. A useful purchasing record might read β€œATX-304 / O-304, sodium salt, selected capsule strength, assigned lot.” Keep an ambiguous search term in a separate notes field so it cannot replace the chemical specification.

The DA listing specifies sodium salt and offers 50 mg and 200 mg capsule variations, each with 60 capsules. A shared development name does not establish that a finished capsule matches the material in a publication. Read the current documentation notes alongside the report.

Common questions

Should OS-01 be used as an unqualified synonym?

No. Identify which compound the source means before importing its claims, chemical identifiers or study results.

Does this page describe OneSkin’s peptide?

No. DA’s linked product is listed as ATX-304 sodium salt. The skin-peptide discussion explains the name collision.

Review the material and its documentation

Connect the literature to the current product specification, then check the assigned batch report and any stated limitations.

Sources

  1. Holm et al. (2025): ATX-304, formerly O304, in a mouse liver-disease model.
  2. Zonari et al. (2024): primary clinical study of the separate topical OS-01 peptide formulation.
  3. Supplier naming example: OS-01 listing describing O304 capsules; not scientific evidence of identity or efficacy.

Publisher disclosure: Disguised Alpha sells the research material linked here. This supplier-published article is educational and is not independent clinical guidance or a systematic review.

Research hub Β· ATX-304 reference

βœ“
Loading...